Kelsey Goodwin
Stock Analyst at Guggenheim
(1.05)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
URGN UroGen Pharma | Maintains: Strong Buy | 15 30 | 18.27 | 64.2% | 3 | Jun 13, 2025 | |
IPSC Century Therapeutics | Reiterates: Buy | n/a | n/a | n/a | 3 | Mar 28, 2025 | |
GNLX Genelux | Initiates Coverage On: Buy | 8 | 3.28 | 143.9% | 1 | Oct 29, 2024 | |
NUVL Nuvalent | Maintains: Strong Buy | 99 105 | 74.98 | 40.04% | 2 | Sep 16, 2024 | |
MGNX Macrogenics | Downgrades: Neutral | n/a | n/a | n/a | 1 | Jul 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | Sep 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | n/a | n/a | n/a | 3 | Jun 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Oct 31, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Oct 31, 2022 |